Decreased COVID-19 vaccine efficacy amongst IBS patients receiving anti-TNFα drugs

By | September 6, 2021
In a paper recently uploaded to the preprint server medRxiv* by Edelman-Klapper et al., the efficacy of the mRNA vaccine is examined amongst IBD patients and compared with healthy volunteers, finding reduced efficacy amongst those receiving anti-TNFα medication.